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ABSTRACT 
 
Objective: Ventilator-induced lung injury is a crucial determinant of the outcome of 
mechanically ventilated patients.  Increasing numbers of mouse studies have identified 
numerous pathways and mediators that are modulated by ventilation, but it is 
conceptually difficult to reconcile these into a single paradigm.  There is substantial 
variability in tidal volumes used in these studies, and no certainty about the 
pathophysiology that such varied models actually represent. This study was designed to 
investigate whether ventilation strategies ranging from ‘very high’ to more ‘clinically-
relevant’ tidal volumes induce similar pathophysiologies in healthy mice, or represent 
distinct entities.  
Design: In vivo study.  
Setting: University research laboratory. 
Subjects: C57/Bl6 mice. 
Interventions: Anesthetized mice were ventilated with various tidal volumes up to 
40ml/kg. 
Measurements and Main Results: Respiratory system compliance and arterial blood 
gases were used to evaluate physiological parameters of injury.  Lung wet:dry weight 
ratio, lavage fluid protein and cytokines were used to assess pulmonary edema and 
inflammation. All ventilation strategies induced changes in respiratory system 
compliance, although the pattern of change was unique for each strategy. Ventilation 
with 10ml/kg and 40ml/kg also induced decreases in arterial pO2 and blood pressure. 
Any physiological changes induced during the 10, 20 and 30ml/kg strategies were 
largely reversed by recruitment maneuvers at the end of the protocol.  Markers of 
pulmonary edema and inflammation indicated that only 40ml/kg induced substantial 
increases in both, consistent with development of lung injury.  
 3 
Conclusions: Tidal volumes up to 20ml/kg are unlikely to induce substantial lung over-
stretch in models using healthy, young mice. Signs of injury/inflammation using such 
models are likely to result from other factors, particularly alveolar derecruitment and 
atelectasis.  The results of such studies may need to be re-evaluated before clinical 
relevance can be accurately determined. 
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INTRODUCTION 
 
The exacerbation of lung injury by mechanical ventilation, known as ventilator-
induced lung injury (VILI), is a crucial consideration in the treatment of critically ill 
patients. Inappropriately high tidal volume (VT) has been clearly identified as a primary 
contributor to mortality among patients with acute respiratory distress syndrome [1], 
and many studies have investigated the mechanisms by which high lung stretch induces 
inflammation and respiratory dysfunction.  In particular the number of mouse studies 
has increased dramatically since the first publications in 2002-2003 [2, 3], taking 
advantage of genetically modified animals and the similarity between the mouse and 
human immune systems. These have identified a plethora of pathways and mediators 
apparently modulated by mechanical ventilation, but it remains difficult to reconcile 
these into a coherent paradigm.   Importantly, there has been huge variability regarding 
experimental protocols in these mouse studies, and whether they are investigating 
similar or distinct phenomena remains unclear.  Specifically, in vivo VILI models 
unavoidably incorporate numerous insults apart from lung stretch, including shear 
forces resulting from repetitive alveolar collapse and reopening, surgical stress, 
anesthesia and others, which are likely to impact upon the outcomes.  
Regarding the modelling of lung overstretch in mice, two general schools of 
thought persist - use of very high VT, and use of moderately high, more ‘clinically 
relevant’ VT.  The rationale behind very high VT strategies (i.e. 30-40 ml/kg) is that 
these are likely to induce similar magnitudes of stretch in the lungs of healthy mice to 
those which occur in the ‘Baby Lung’ of ARDS patients [3-13], although these 
protocols are frequently criticized as being too extreme to have any relevance to 
humans.  Attempts to mimic more clinically comparable injurious VT (i.e. 10-20ml/kg) 
in mice have also been widely used [14-22], with authors claiming that this is more 
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relevant in light of the Acute Respiratory Distress Syndrome Network trial [1] which 
identified ~12ml/kg as being injurious (compared to ~6ml/kg).  However, as mice have 
entirely different respiratory mechanics from humans [23, 24], these assumptions may 
not be physiologically valid, and such studies could be misleading.    
This study therefore aimed to compare the impact of different VT on the 
development of lung injury in mice. Overall, our data indicate that so-called ‘clinically-
relevant’ VT in mice are indeed unlikely to induce high lung stretch, and that other 
factors within the models such as alveolar derecruitment dominate the pathophysiology.  
Careful evaluation/re-evaluation of mouse-based VILI studies will be important to 
clarify what pathophysiological processes dominate within particular models, and thus 
how to properly interpret the results of such studies and their translation towards clinical 
situations. 
 
 
MATERIALS AND METHODS 
Animal preparation 
All experimental protocols were approved by the Ethical Review Board of Imperial 
College London, and carried out under the authority of the UK Home Office in 
accordance with the Animals (Scientific Procedures) Act 1986.  Male C57Bl/6 mice 
(Charles River, Margate, UK) aged 8-12 weeks were randomly allocated to receive 
either no treatment (non-ventilated controls (NVC)) or one of the ventilation protocols 
as described below.  NVC received no surgery and were killed by anesthetic overdose.  
Ventilated animals were anesthetised with ketamine (80 mg/kg) and xylazine (8 mg/kg), 
an endotracheal tube was inserted via tracheotomy, and mice were ventilated using a 
custom-made, volume-controlled mouse ventilator system [3, 25].  Airway flow was 
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determined using a miniature pneumotachograph connected to a differential pressure 
transducer, which was calibrated at the start of every experiment. VT was calculated by 
integrating airway flow during inspiration. Airway pressure was determined by a 
transducer connected to the ventilator circuit. Inspiratory:expiratory ratio was kept 
constant at 1:2 throughout the experiment.  A catheter was introduced into the left 
carotid artery for monitoring of arterial blood pressure, blood gas analysis, and infusion 
of fluids (0.9% NaCl containing 10U/ml heparin at 0.3ml/hr).  Anesthesia was 
maintained by regular intraperitoneal administrations of ketamine (40mg/kg) and 
xylazine (4mg/kg) every 25-30 minutes.  
 
Protocols and physiological measurements 
All animals were ventilated with a respiratory rate of 80 breaths/minute and 
positive-end expiratory pressure (PEEP) of 3cmH2O throughout the procedures.  
Following baseline physiological measurements to ensure stability of the preparation, 
mice were allocated to receive one of the following strategies: VT 40ml/kg, using air/4% 
CO2; VT 30ml/kg using air/4% CO2; VT 20ml/kg using air/2% CO2; VT 10ml/kg using 
air (no supplemental CO2).  Additionally, a group of animals were ventilated using this 
lowest VT but with the addition of recruitment maneuvers (RM, 35cmH2O, 5 seconds) 
every 30 minutes throughout. CO2 was added to inspired gases for groups with VT > 
10ml/kg to avoid respiratory alkalosis.   
Ventilation was continued for 3 hours, or until BP dropped below 50mmHg.  
Preliminary experiments determined that this was the maximum period over which mice 
ventilated with either of the ‘extremes’, i.e. 10ml/kg (without RM) and 40ml/kg 
remained hemodynamically stable. At the end of each protocol, 2 RM were carried out 
to assess reversibility of changes in physiological variables.  Respiratory system 
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compliance was determined by the end-inflation occlusion technique [3, 25] at the start 
of the ventilatory protocol and every 15 minutes until the end.  Blood gas analyses were 
performed at baseline, 15 and 120 minutes after the start of the protocol, and at the end 
of the protocol.  To prevent hypovolemia, blood sampling was limited to 70µl, and the 
volume replaced with saline each time.   
 
Sample collection 
Following termination, the right lung was tied off and used to determine wet:dry 
weight ratio. The left lung was lavaged using 400µl sterile saline (recovering ~200-
300µl, depending on the presence of edema fluid within the lungs).  Lavage fluid was 
centrifuged (5 minutes, 1500 rpm (210g), 4˚C), and supernatants stored at -80˚C.  Cell 
pellets were resuspended, counted by hemacytometer, and differential cytology carried 
out on Diff-Quik stained slides prepared by cytospin. Protein concentration in lavage 
fluid was determined using a protein assay kit (Bio-Rad Laboratories, Hemel 
Hempstead, UK).  Lavage fluid levels of interleukin (IL)-6, keratinocyte-derived 
chemokine (KC) and soluble Receptor for Advanced Glycation End-products (sRAGE) 
were determined by enzyme-linked immunosorbent assay (R&D Systems, Abingdon, 
UK).   
 
Histology  
 
In some animals, at the end of the protocol the heart and lungs were removed en 
bloc.  Lungs were instilled with 4% paraformaldehyde via a fine cannula passed through 
an extended endotracheal tube, to produce a pressure of ~15cmH2O.  Lungs were 
paraffin embedded and processed for histological evaluation by hematoxylin and eosin 
staining. 
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Pressure-volume curves 
In separate experiments, pressure-volume curves of the respiratory system were 
created by ventilating anesthetized mice with 3cmH2O PEEP and respiratory rate of 80 
breaths/minute, with gradually increasing inspiratory flow.  Each breath incorporated an 
end-inspiratory pause, and curves were created by plotting plateau pressure against 
delivered VT. 
 
Data Analysis 
Data were analysed by one-way analysis of variance with Tukey’s post test using 
SPSS 19.0 (IBM, Armonk, NY). A p value < 0.05 was considered significant.  The 
model assumption of normality of residuals was assessed by QQ plot and Shapiro-Wilk 
test, and log-transformed where necessary. Data are presented as mean with error bars 
representing upper and/or lower limit of 95% confidence interval [26]. 
 
 
RESULTS 
Cardiorespiratory variables 
Arterial blood pressure was well maintained (80-100mmHg) in all groups up to 2 
hours of ventilation, whereupon it fell substantially in both the 40ml/kg and 10ml/kg 
(without RM) groups, but not others (Fig 1A).  In most groups all animals were 
ventilated for the full 3 hours, the exception being 40ml/kg VT, within which animals 
reached the 50mmHg ‘cut-off for hemodynamic stability’ at different times as injury 
developed.  The average length of ventilation in this group was 153±20 minutes 
(mean±SD).   Kaplan-Meier analysis (using 50mmHg blood pressure as a surrogate for 
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death) indicated significantly worse survival with 40ml/kg compared to all other groups 
(Fig 1B). 
Each ventilatory strategy induced an overall increase in peak inspiratory pressure, 
but the patterns of change were qualitatively different (Fig 1C).  10ml/kg VT (without 
RM) induced a gradual, continuous increase in peak inspiratory pressure over 3 hours.  
VT 20ml/kg and 30ml/kg both induced initial increases followed by stable peak 
inspiratory pressure for the remainder of the protocol.  In contrast, mice ventilated with 
40ml/kg showed an initial decrease in PIP, followed by a substantial, rapidly 
progressing increase. These changes were mirrored by respiratory system compliance, 
in which 10ml/kg, 20ml/kg and 30ml/kg all induced immediate decreases of varying 
magnitude, whereas 40ml/kg only induced a decrease in respiratory system compliance 
towards the end of the protocol, following an initial increase (Fig 1D).  Use of RM at 
the end of the protocols reversed any changes in respiratory mechanics close to their 
initial values, in all groups except 40ml/kg.  Furthermore, frequent use of RM every 30 
minutes throughout the 10ml/kg protocol (10ml/kg + RM group) prevented the on-
going deterioration with this VT (Fig 1C/D).   
Arterial oxygenation was well maintained over 3 hours (pO2 >90torr (12kPa)) in 
most of the ventilated groups (Fig 2A), except for those animals ventilated using 
10ml/kg (without RM) and 40ml/kg VT.   However, most of the deterioration of pO2 in 
the 10ml/kg (without RM) group was found to be reversible by RM at the end of the 
protocol.  pCO2 (Fig 2B) increased between 15 to 120 minutes in all animals ventilated 
with VT ≤20ml/kg, most noticeably those using 10ml/kg without RM, and this was again 
to some degree reversible by RM at the end.  In contrast, animals ventilated using 
30ml/kg showed no pCO2 increase over the entire 180 minutes, and animals ventilated 
with 40ml/kg only showed an increase during the final 60 minutes (coinciding with the 
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decrease in pO2).  Arterial pH was similar (range 7.34-7.39) between all of the groups at 
15 minutes after the beginning of ventilation, indicating that the combinations of VT and 
inspired CO2 were appropriate to avoid respiratory alkalosis.  Subsequently, pH 
decreased in all animals, although remained above 7.25 in all groups except animals 
ventilated with 10ml/kg (without RM) or 40ml/kg (Fig 2C). 
 
Pulmonary edema/permeability  
To evaluate alveolar-capillary barrier permeability and pulmonary edema, lavage 
fluid protein content and lung wet:dry ratios were determined in all ventilated groups, 
and compared with data of non-ventilated animals.  In the group ventilated using 
10ml/kg + RM throughout, lung wet:dry ratio was only marginally increased (~8%, 
non-significant (p=0.733)) compared to untreated NVC mice (Fig 3A).  The increase in 
wet:dry ratio was enhanced to a similar degree (up to 20-30%) in animals ventilated 
using 10ml/kg without RM (p<0.01 vs. NVC), 20 ml/kg (p<0.001 vs. NVC) and 
30ml/kg (p<0.05 vs. NVC).  In contrast, wet:dry ratio was considerably greater 
following 40ml/kg ventilation compared to all other strategies (~70% increase vs. 
NVC).  Lavage fluid protein showed a very similar pattern (Fig 3B), with levels in the 
10ml/kg + RM group similar to NVC, a moderate increase in animals ventilated with 
10-30 ml/kg VT, but much higher with 40 ml/kg.  It is important to note that wet:dry 
ratio and lavage fluid protein did not increase when VT was raised from 10 to 20 to 30 
ml/kg.  
 
Pulmonary Inflammation 
Consistent with previous studies [27, 28] there was minimal recruitment of 
neutrophils into the alveolar space within the 3 hour timeframe of this ventilation 
 11 
protocol (none of the VT groups induced a neutrophil content of >6% lavage cells – data 
not shown).  There was however clear upregulation of soluble inflammatory markers 
within the alveolar space.  Lavage fluid keratinocyte-derived chemokine (a functional 
homologue of IL-8) and IL-6 showed very similar patterns, with significant 
upregulation only seen following 30 and 40ml/kg ventilation (Fig 4A/B).  In contrast, 
the pattern of sRAGE expression was somewhat different (Fig 4C), with 10ml/kg 
(without RM) and 20ml/kg both increasing sRAGE compared to NVC animals, while 
30ml/kg did not (p=0.08).  Intriguingly the 10ml/kg + RM group had significantly lower 
levels of sRAGE than the 10ml/kg without RM animals.  As with all other markers, 
40ml/kg induced the most substantial upregulation.   
 
Histology  
Histological examination of the lungs indicated minimal change following 
ventilation using 10ml/kg (without RM), despite the substantial changes in respiratory 
mechanics induced by this strategy (Fig 5).  In contrast, ventilation with 40ml/kg caused 
increased infiltration of neutrophils into the lung tissue, as well as signs of alveolar wall 
thickening and the presence of proteinaceous material within the alveolar space.   
 
Pressure-volume curves 
Individual plateau pressure - volume (VT) curves were determined for 5 mice (Fig 
6A).  In all animals, following an initial steep gradient in the curve there was an 
inflection point above which the curve started to flatten.  This occurred between 13-16 
cmH2O plateau pressure, corresponding to ~24-28ml/kg VT.  Importantly however, after 
this point the curve did not flatten completely, indicating that the lung continues to 
expand even when plateau pressure was increased >60 cmH2O (delivered VT 
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>50ml/kg). Furthermore, all animals subjected to this protocol began to breath 
spontaneously within 5 minutes of switching to continuous positive airway pressure 
(Fig 6B), indicating that application of such high pressures/volumes do not apparently 
produce life-threatening lung damage immediately in mice.   
 
 
DISCUSSION 
Despite substantial research into the pathophysiology of VILI our understanding 
remains limited. Of the various factors which may cause injury, high tidal volume is 
most widely accepted as contributing to mortality among patients [1, 29-31], with tidal 
volumes of 10-15ml/kg considered injurious in humans.  In contrast, the importance of 
other factors, such as atelectasis promoting alveolar collapse and reopening remain 
much less clear.  For example, recent systematic reviews and meta-analyses have been 
unable to conclusively show that prevention of atelectasis by increased PEEP or 
recruitment manoeuvres produces a significant mortality benefit [32-35].  Most animal 
models of ‘pure’ VILI are therefore generally designed to incorporate lung stretch as an 
injurious factor.  However, it is far from certain that all animal models actually induce 
substantial lung stretch.  Experimentally, attempts to investigate this ‘high stretch-
induced lung injury’ in mice have used VT ranging from 12-45ml/kg, under the apparent 
assumption that these are merely degrees on a ‘continuum of stretch’.  In fact, such 
strategies almost certainly represent entirely different pathophysiological processes.  
In the current study we found that ventilation with 10ml/kg in the absence of 
recruitment maneuvers induced deteriorations in respiratory system mechanics and 
blood pressure to such an extent that 3 hours was the maximum period over which 
hemodynamic stability could be assured.  In addition, lung wet:dry ratio and lavage 
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fluid protein were both moderately, but clearly greater than observed in untreated mice 
(~20% increase in wet:dry ratio, ~4x increase in BAL protein), which could be 
interpreted as indicative of stretch-induced injury.  Importantly however, in the current 
study these changes were substantially attenuated by the inclusion of RM throughout 
ventilation, strongly suggesting that with this VT the major contributor to lung ‘injury’ 
is in fact atelectasis-related, despite use of 3cmH2O PEEP throughout. In fact, it has 
been shown recently that even 6cmH2O PEEP could only slow down, but not prevent 
derecruitment and atelectasis during ‘low’ VT ventilation in mice [36]. Furthermore, 
neither lavage fluid protein nor lung wet:dry ratio were further increased when VT was 
raised as high as 30ml/kg.  If the alveolar-epithelial permeability observed at 10 or 
20ml/kg were due to lung over-stretch, we should expect greater changes at 30ml/kg, 
which was not the case.  These results provide evidence that the apparent injury 
(compared to untreated NVC animals) observed with VT <30ml/kg is related to other 
aspects of the experiment than overstretching the lung.  In addition to atelectasis, the 
potential influence of supine positioning, surgical stress, anesthesia and dry gas 
ventilation could all be important.  Our findings also highlight the dangers inherent in 
the sole use of non-ventilated animals as controls in studies designed to investigate 
pathophysiological processes induced by lung stretch.  
Previously, it was reported in rats that irrespective of ventilation strategy, 
equivalent changes in respiratory mechanics equate to equivalent degrees of lung injury 
[37].  In contrast, the current data demonstrate clearly that the pattern, rather than the 
degree of mechanics changes, reflects the development of alveolar-epithelial barrier 
dysfunction in mice. The characteristic ‘late’, rapid decrease in compliance in the 
40ml/kg very high VT group is likely to reflect on-going pulmonary edema development 
with this strategy, as confirmed by lavage fluid protein and lung wet:dry ratio, whereas 
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early, linear changes observed in lower VT groups would reflect derecruitment.  Indeed, 
the changes in respiratory system mechanics at 10, 20 and 30ml/kg VT were largely 
reversible by RM at the end of experiment, whereas those at 40ml/kg VT were not. The 
difference between our study and the previous one in rats may reflect species 
differences, including fundamental physical properties of the mouse lung [24] and the 
extraordinarily low elastance of the mouse chest wall [38].  
We found no neutrophil influx into the alveolar space within 3 hours, consistent 
with previous studies showing that even with inhaled lipopolysaccharide, substantial 
neutrophil influx does not occur until ~4 hours after challenge [39].  Leukocyte 
accumulation was however apparent on histological examination of lung tissue, 
presumably within the intravascular or interstitial space, following 40ml/kg VT.  In 
contrast, proinflammatory cytokines keratinocyte-derived chemokine and IL-6 were 
upregulated within lavage fluid by 30ml/kg and, more substantially 40ml/kg, but not the 
other VT strategies.  The epithelial injury/dysfunction marker sRAGE [40] showed a 
somewhat different pattern, with 10ml/kg and 20ml/kg both inducing a greater level of 
sRAGE than was observed with 30ml/kg. We speculate that at VT ≤20ml/kg the 
increases in sRAGE are a consequence of atelectasis-induced epithelial shear stress, 
rather than lung over-stretch, supported by the fact that animals ventilated with 10ml/kg 
+ RM throughout displayed similar sRAGE levels to untreated mice. To the best of our 
knowledge this is the first description of the impact of VILI on sRAGE, and the data 
suggest that this follows the pattern of permeability/edema markers (lavage fluid protein 
and wet:dry weight ratio) more closely than the pattern of inflammatory cytokine 
production. 
In the current study, only a VT of ~40ml/kg induced substantially greater 
pulmonary edema/epithelial permeability and inflammation compared to the other 
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ventilation strategies used.  With a VT of 30ml/kg there were no substantial 
physiological changes over 3 hours, but lavage fluid cytokines (keratinocyte-derived 
chemokine and IL-6) showed clear increases.  This suggests that at this level the VT is 
sufficiently high to recruit any lung areas with a tendency to collapse at end-expiration 
(further supported by the low sRAGE levels in this group), and lung stretch begins to 
dominate the pathophysiology over atelectasis, which appears to be the primary 
‘injurious’ factor at lower VT.  While such a VT of 30-40 ml/kg undoubtedly looks very 
high, it is important to bear in mind a number of considerations.  Firstly, this is 
reflective of the nature of mouse respiratory mechanics which, as demonstrated by the 
PV curves, are substantially different from that of humans.  Although the method used 
to produce the PV curves in this study was not entirely conventional (as they were 
dynamically measured during tidal mechanical ventilation), this method allowed us to 
demonstrate that mice were able to tolerate the apparently extreme pressures/volumes 
achieved and return to spontaneous breathing.  Furthermore, the data obtained are 
consistent with previous studies using alternative static techniques [23].  Secondly, our 
data should be considered within the context of uninjured lungs.  The effects of stretch 
with such high VT in healthy mouse lungs are likely to be comparable to that induced 
regionally by lower VT in either ventilated ARDS patients (due to heterogeneous injury 
and ‘Baby Lung’ [41]) or so-called ‘2-hit’ models of VILI.  Both of these situations 
involve pre-injured or pre-stimulated lungs, which would significantly enhance the 
sensitivity of lung tissues to stretch.  It is also relevant to appreciate that any form of 
airway manipulation within small animals, e.g. delivery of intratracheal agents, is likely 
to induce sufficient alteration in respiratory mechanics as to constitute a ‘hit’.  
Therefore, ‘clinically comparable’ VT in mice may potentially be useful to produce 
 16 
stretch-induced injury in the case of 2-hit models [42], although as models become 
more complicated it is harder to dissect the contribution of stretch versus other insults.  
Finally, it is worth clarifying that the ‘numbers’ reported here for tidal volumes 
should not be considered absolute. The precise VT that causes substantial stretch to the 
lung will be influenced to a greater or lesser extent by mouse weight, age, strain, 
ventilator waveform, anesthetic regimen, and so on.  More important is the appreciation 
that with in vivo mouse ventilation, VT should not simply be considered as a continuum 
of stretch, i.e. with 12ml/kg overstretching lungs and 40 ml/kg overstretching them 
more, as our data suggest that this is not the case.  In our opinion, studies on lung 
stretch (particularly those reporting interventions to alleviate the consequences of 
stretch) should demonstrate that the pattern of mechanics change is consistent with late 
edema formation rather than early derecruitment, and/or that outcomes are not 
reversible by recruitment.   
Somewhat in contradiction to our findings, a number of mouse studies using 1-hit 
‘pure VILI’ models have demonstrated differences between ‘injurious’ 15-20ml/kg and 
lower ‘non-injurious’ VT [14, 16-22]. However, most of these studies [14, 17, 21, 22], 
and many others in the VILI arena, utilise not only different VT among groups, but also 
different respiratory rate, to manage pCO2. It has been proposed [43] that higher 
respiratory rate during VILI may exacerbate epithelial/endothelial damage but attenuate 
cytokine production.  Studies incorporating altered respiratory frequency may therefore 
introduce unknown variables into the model, greatly complicating their interpretation. 
 
CONCLUSIONS 
In summary, all of the data in our study indicate that VT ≤20ml/kg is unlikely to 
induce excessive stretch in the lungs of otherwise healthy ventilated mice; rather, the 
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observed changes in protein permeability, gas exchange, wet:dry ratio, and 
inflammatory markers appear to be primarily a result of other factors, particularly 
atelectrauma. This highlights an important point that ‘non-ventilated’, uninjured animals 
are generally not the most appropriate controls for injurious high VT ventilation because 
multiple confounding factors exclude us from being able to interpret changes as due to 
stretch. Differences in respiratory system mechanics between species mean that the 
definition of ‘high VT’ in a model using healthy mice should not be driven by what 
represents a high VT in injured human lungs. We conclude that ‘clinically relevant’ tidal 
volumes taken from human experience are unlikely to induce a ‘clinically relevant’ 
injury in healthy mice, and that mediators and pathways identified using such models 
may need to have their translational importance to stretch-induced lung injury re-
evaluated.   
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FIGURE LEGENDS 
 
Figure 1. A) Time course of change in arterial blood pressure during ventilation.  B) 
Kaplan-Meier analysis, using 50mmHg as a surrogate for death, indicated that 40ml/kg 
VT induced significantly higher ‘mortality’ than all other ventilation strategies (*p<0.05 
by Log-rank test).  C) Change in peak inspiratory pressure, and D) change in respiratory 
system compliance during ventilation.  Each VT strategy induced distinct patterns of 
changes in peak inspiratory pressure (PIP) and compliance (Crs).  VT 10ml/kg, 20ml/kg 
and 30ml/kg all induced increased PIP and decreased Crs which started immediately, 
but were largely reversible by recruitment maneuvers (RM) carried out at the end.  The 
changes observed during 10ml/kg VT were effectively prevented by RM throughout the 
protocol (10ml/kg + RM group).  In contrast, 40ml/kg induced an initial decrease in PIP 
and increase in Crs (presumably a result of continuous alveolar recruitment), which 
only deteriorated towards the end of the protocol, and were not reversible by RM. The 
variability in PIP and Crs apparent towards the end of the 40ml/kg protocol was 
primarily due to loss of animals as they became hemodynamically unstable at different 
times.  Data are presented as mean with error bars representing upper or lower limit of 
95% confidence interval.  N=4-6 / group (at the start of experiments). 
 
Figure 2. Time course of change in arterial oxygenation (A), carbon dioxide (B) and pH 
(C) during ventilation. Blood gases were well maintained in most of the groups 
throughout 3 hours.  The exceptions were 10ml/kg (without RM) and 40ml/kg, which 
showed substantial deteriorations. Changes in parameters were substantially reversed by 
recruitment maneuvers at the end of the 10ml/kg but not the 40ml/kg strategy, although 
it should be noted that post-RM blood gases could only be evaluated in a very small 
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number of 40ml/kg animals due to their extremely low blood pressure at this point. Data 
are presented as mean with error bars representing upper or lower limit of 95% 
confidence interval.  N=4-6 / group (at the start of experiments). 
 
Figure 3. Alveolar-epithelial barrier permeability assessed by lung wet:dry weight ratio 
(A) and lavage fluid protein (B) following ventilation.  Both 10 and 20ml/kg VT 
marginally increased wet:dry ratio and lavage fluid protein compared to non-ventilated 
control (NVC) mice. The addition of RM throughout (10ml/kg + RM) attenuated any 
changes induced by 10ml/kg ventilation, whereas 30ml/kg VT did not lead to any further 
increases in markers of permeability.  In contrast, 40ml/kg VT induced substantial 
changes in both markers compared to all other groups.  For wet:dry ratio (A), data were 
log-transformed for analysis and back-transformed for display.  Confidence intervals are 
therefore not symmetrical around the mean, so data are presented as (geometric) mean 
with error bars representing upper and lower limit of 95% confidence interval.  For 
lavage protein (B), data are presented as (arithmetic) mean with error bars representing 
upper and lower limit of 95% confidence interval. N=4-5 / group.  *p<0.05, **p<0.01, 
***p<0.001 by ANOVA with Tukey’s post test. 
 
Figure 4.  Intra-alveolar inflammation evaluated by lavage fluid levels of keratinocyte-
derived chemokine (KC) (A), interleukin (IL)-6 (B) and soluble receptor for advanced 
glycation end-products (sRAGE) (C).  KC and IL-6 levels were only increased 
following 30 or 40ml/kg VT compared to untreated NVC animals.  In contrast, both 
10ml/kg (without RM) and 20ml/kg somewhat increased sRAGE, whereas 30ml/kg did 
not.  The addition of RM throughout the 10ml/kg protocol (10ml/kg + RM) attenuated 
sRAGE levels virtually back to those observed in NVC.  The 40ml/kg protocol led to 
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significantly increased sRAGE, compared to all other groups. For KC (A) and sRAGE 
(C), data were log-transformed for analysis and back-transformed for display.  Data are 
presented as (geometric) mean with error bars representing upper and lower limit of 
95% confidence interval.  For IL-6 (B), data are presented as (arithmetic) mean with 
error bars representing upper and lower limit of 95% confidence interval. N=4-5 / 
group.  *p<0.05, **p<0.01, ***p<0.001 by ANOVA with Tukey’s post test. 
 
Figure 5.  Histological examination indicated minimal changes between samples from 
untreated non-ventilated control (NVC) mice and ventilation with 10ml/kg (without 
RM). In contrast, ventilation with 40ml/kg promoted increased infiltration of 
neutrophils into the lung tissue (closed arrows), as well as alveolar wall thickening and 
the presence of proteinaceous material within the alveolar space (open arrows).  
Magnification x400. 
 
Figure 6.  Pressure-volume curve of 5 individual mice (A).  Mice were ventilated using 
positive-pressure ventilation with an increasing inspiratory flow.  VT was plotted against 
plateau pressure (Pplat).  There was no flattening of the curves after reaching an 
inflection point at ~24-28ml/kg, indicating that the lungs continued to expand even up 
to 50-60ml/kg. B, real-time recordings of airway flow and peak inspiratory pressure 
against time during pressure-volume determination experiments.  Within 5 minutes of 
switching from positive pressure ventilation to continuous positive airway pressure 
(CPAP), all mice began spontaneous breathing, indicating that even inflation up to VT 
60ml/kg / ~65 cmH2O Pplat does not cause overt, immediate lung damage. 
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